Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

10 Nov 2014 07:00

RNS Number : 5259W
Kingspan Group PLC
10 November 2014
 

Kingspan Group Plc

Interim Management Statement

 

10 November 2014

 

Kingspan Group plc, the global leader in high performance insulation and building envelopes, today issues the following Interim Management Statement, with trading information for the period from 1 July to 30 September 2014.

 

Sales in the nine month period to 30 September were €1.39bn, up 5% on the prior year (+5% constant currency). A solid sales performance was also recorded in the third quarter with revenue up 7% (+5% constant currency) compared to the same period in 2013.

Insulated Panels revenue in the first nine months increased by 9% (+9% constant currency), and by 8% (+7% constant currency) in the third quarter. The UK continued to perform well with encouraging activity across most building segments. After a sluggish second quarter sales performance, Mainland Europe remained weak through the third quarter reflecting somewhat of an abatement in German market activity. The pace of sales growth in North America improved in the third quarter helped by a strong order book as we entered the second half. Order intake also showed a significant improvement over prior year. Activity in Australasia continued the strong trend evident in the first half.

Insulation Board revenue in the first nine months was up 3% (+1% constant currency) compared with the same period last year, and ahead by 6% in quarter three (+2% constant currency). The UK sales performance was positive through the third quarter, and Mainland European sales were relatively stable overall year on year. Further progress in market conversion was evident in Australia during the third quarter.

Environmental revenue in the first nine months was ahead of last year by 1% (-2% constant currency) and by 3% (-3% constant currency) in the third quarter, continuing on the path of relative stabilisation seen earlier in the year.

Access Floors revenue in the first nine months was 4% behind the same period last year (-4% constant currency). Sales in the third quarter were ahead by 11% (+8% constant currency) with continuing momentum evident in UK office construction activity and an improvement in the US relative to a weak first half.

 Net debt at the end of September 2014 was €107.7m, €39.1m lower than at the same point in 2013. The fourth quarter is a seasonally cash generative period and this would indicate net debt levels by year end in the region of €140m after taking account of the acquisitions of Pactiv Insulation (North America) and PAL (UAE). These insulation board businesses were separately acquired in October for a combined consideration of €77m.The relative optimism that prevailed earlier in the year appears to have waned in recent months, particularly in Europe. Whilst our business continues to perform solidly, we nonetheless are mindful of what are currently more tempered 2015 economic forecasts, and remain focused on driving the Kingspan proposition, whatever the macro climate.

The fourth quarter of 2013 was particularly strong for the Group. Notwithstanding that, and with this seasonally important and often variable period to come, we expect to deliver a full-year trading profit in the region of €144m (+17% versus 2013).

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBGUGBGSR
Date   Source Headline
1st Jul 201511:02 amRNSTotal Voting Rights
26th Jun 20155:14 pmRNSDirectorate Change
17th Jun 20154:16 pmRNSHolding(s) in Company
15th Jun 20155:13 pmRNSDirector/PDMR Shareholding
2nd Jun 20159:45 amRNSTotal Voting Rights
28th May 20154:49 pmRNSHolding(s) in Company
21st May 20159:47 amRNSHolding(s) in Company
21st May 20157:00 amRNSAcquisition completion
20th May 20155:58 pmRNSHolding(s) in Company
20th May 20155:24 pmRNSHolding(s) in Company
20th May 20157:00 amRNSAcquisition update
12th May 20159:56 amRNSHolding(s) in Company
7th May 201510:36 amRNSDirectorate Change
7th May 201510:31 amRNSAGM Results
7th May 20157:00 amRNSInterim Management Statement
1st May 20157:00 amRNSTotal Voting Rights
22nd Apr 20154:18 pmRNSDirector/PDMR Shareholding
1st Apr 20159:54 amRNSTotal Voting Rights
25th Mar 20154:38 pmRNSHolding(s) in Company
24th Mar 201512:22 pmRNSAnnual Financial Report
23rd Mar 20153:05 pmRNSTransaction in Own Shares
23rd Mar 20152:51 pmRNSAcquisition Update
19th Mar 20151:52 pmRNSHolding(s) in Company
16th Mar 20155:04 pmRNSAcquisition
13th Mar 201510:20 amRNSHolding(s) in Company
10th Mar 20156:11 pmRNSHolding(s) in Company
5th Mar 201512:16 pmRNSDirector/PDMR Shareholding
3rd Mar 201511:47 amRNSHolding(s) in Company
2nd Mar 201510:34 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSMain Securities Market Notice
27th Feb 20153:12 pmRNSDirector/PDMR Shareholding
27th Feb 20153:12 pmRNSDirector/PDMR Shareholding
25th Feb 20154:27 pmRNSHolding(s) in Company
24th Feb 20155:18 pmRNSDirector/PDMR Shareholding
24th Feb 20155:08 pmRNSBlock Listing Application
24th Feb 20155:07 pmRNSDirector/PDMR Shareholding
24th Feb 20155:02 pmRNSDirector/PDMR Shareholding
23rd Feb 20157:00 amRNSFinal Results
10th Feb 201510:23 amRNSHolding(s) in Company
9th Feb 20159:36 amRNSHolding(s) in Company
30th Jan 201512:16 pmRNSHolding(s) in Company
27th Jan 20157:01 amRNSAcquisition
26th Jan 20157:00 amRNSStatement re. Press Comment
13th Jan 201512:32 pmRNSHolding(s) in Company
12th Jan 20153:00 pmRNSHolding(s) in Company
6th Jan 20155:31 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSBlocklisting Interim Review
2nd Jan 20157:00 amRNSTotal Voting Rights
17th Dec 20144:58 pmRNSHolding(s) in Company
1st Dec 201411:08 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.